Skip to main content

Lane Michael's Form 4 filing

IDEXX Laboratories Inc (IDXX) · filed Aug 8, 2025

Accession no.
0000874716-25-000125
Filed
Aug 8, 2025
Trade date
Aug 6, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.28M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lane MichaelCIK 0001740689Officer (Executive Vice President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2025Common StockMOption exerciseAcquired+1,286$206.94+$266,124.848,417.94Direct
Aug 6, 2025Common StockMOption exerciseAcquired+7,125$288.78+$2,057,557.515,542.94Direct
Aug 6, 2025Common StockSSaleDisposed−5,631$627.56F2−$3,533,790.369,911.94Direct
Aug 6, 2025Common StockSSaleDisposed−2,480$627.99F3−$1,557,415.27,431.94Direct
Aug 6, 2025Common StockSSaleDisposed−300$628.89F4−$188,6677,131.94Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2025Common StockMOption exerciseDisposed−1,286$0.00$00Direct
Aug 6, 2025Common StockMOption exerciseDisposed−7,125$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average price of the shares sold ranging from a low of $626.70 to a high of $627.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average price of the shares sold ranging from a low of $627.70 to a high of $628.62 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average price of the shares sold ranging from a low of $628.82 to a high of $628.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)